|
Yale SPORE in Skin Cancer
|
5P50CA121974-02
|
$2,233,300
|
HALABAN, RUTH
|
YALE UNIVERSITY
|
|
YALE COMPREHENSIVE CANCER CENTER
|
2P30CA016359-29
|
$1,871,000
|
EDELSON, RICHARD
|
YALE UNIVERSITY
|
|
Wound Response Genes in Cancer Progression
|
1R01CA118750-01A2
|
$300,024
|
CHANG, HOWARD
|
STANFORD UNIVERSITY
|
|
Word on the Street - Creating Multigenerational Prostate Cancer Dialogue
|
5R21CA119976-02
|
$142,980
|
SCHOENFELD, ELINOR
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
Wine for Cancer-Associated Anorexia
|
1R01CA124614-01A1
|
$211,540
|
JATOI, AMINAH
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
Whole Body Hyperthermia and Anti-Tumor Immune Response
|
5R01CA071599-09
|
$280,252
|
REPASKY, ELIZABETH
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Washington University Small Animal Imaging Resource
|
5U24CA083060-09
|
$645,635
|
ACKERMAN, JOSEPH
|
WASHINGTON UNIVERSITY
|
|
VPF/VEGF in normal and neoplastic skin angiogenesis
|
5R01CA069184-12
|
$145,925
|
DETMAR, MICHAEL
|
SWISS FEDERAL INST OF TECH (ETH ZURICH)
|
|
Visualizing Tumors and Mechanisms of Therapy in Vivo
|
5R01CA080006-08
|
$234,613
|
NEGRIN, ROBERT
|
STANFORD UNIVERSITY
|
|
Virus-host interactions in hepatocarcinogenesis
|
1P01CA123328-01A1
|
$1,060,016
|
OU, J-H
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
VHL and FGFR signaling in angiogenesis
|
5R01CA109860-04
|
$283,792
|
HSU, TIEN
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
VEGF-based Targeted Imaging of Tumor Vasculature
|
2R44CA113080-02A2
|
$545,177
|
Backer, Joseph
|
SIBTECH, INC.
|
|
VEGF mRNA Expression Mechanisms in Hypoxia
|
2R01CA064436-11A2
|
$271,728
|
CLAFFEY, KEVIN
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
|
VEGF Induced Signal Transduction
|
5R01CA086289-08
|
$301,024
|
SIBINGA, NICHOLAS
|
YESHIVA UNIVERSITY
|
|
Vav3 Oncogene in Prostate Cancer
|
1R01CA119935-01A2
|
$266,322
|
LU, SHAN
|
UNIVERSITY OF CINCINNATI
|
|
Validation of potential early diagnostic and prognostic markers for pancreatic ca
|
5R21CA115478-02
|
$110,694
|
CHIAO, PAUL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Validation of genomic targets in melanoma
|
5R01CA114337-03
|
$287,615
|
KASHANI-SABET, MOHAMMED
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
UW Comprehensive Cancer Center Support
|
2P30CA014520-34
|
$4,748,000
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-34S1
|
$56,723
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-34S2
|
$239,556
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UTMDACC SPORE in Breast Cancer
|
3P50CA116199-03S1
|
$398,581
|
HORTOBAGYI, GABRIEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
UTMDACC SPORE in Breast Cancer
|
5P50CA116199-03
|
$2,180,817
|
HORTOBAGYI, GABRIEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
UT M.D. Anderson Cancer Center SPORE in Melanoma
|
3P50CA093459-04S1
|
$61,594
|
GRIMM, ELIZABETH
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
UT M.D. Anderson Cancer Center SPORE in Melanoma
|
5P50CA093459-04
|
$2,158,606
|
GRIMM, ELIZABETH
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
UT M.D. Anderson Cancer Center
|
2U10CA045809-19
|
$1,362,206
|
FISCH, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Using NMD to identify Mutated genes in colon cancer
|
5R01CA109256-04
|
$323,890
|
IONOV, YURIJ
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Use of Serum HPV16 DNA as a Marker for Oropharyngeal Cancer Recurrence
|
1R03CA128110-01A1
|
$77,000
|
STURGIS, ERICH
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Use of Quantitative RT-PCR for Staging Esophageal Cancer
|
5R01CA090665-07
|
$260,665
|
LUKETICH, JAMES
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Use of Cystatin C to Combat TGF-Beta Tumorigenesis
|
7R01CA114039-03
|
$255,996
|
SCHIEMANN, WILLIAM
|
UNIVERSITY OF COLORADO DENVER/HSC AURORA
|
|
Use of Adjuvants to Improve Skin Genetic Immunizations
|
5R01CA100893-04
|
$256,389
|
LARREGINA, ADRIANA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Use of aAPC for melanoma adoptive immunotherapy
|
5R01CA108835-04
|
$317,808
|
SCHNECK, JONATHAN
|
JOHNS HOPKINS UNIVERSITY
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
5P30CA014089-32
|
$6,578,401
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Urokinase Receptor-initiated Cell-signaling
|
2R01CA094900-07
|
$268,676
|
GONIAS, STEVEN
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Urokinase Receptor Integrin Interactions in Lung Cancer
|
1R01CA125564-01A1
|
$292,600
|
CHAPMAN, HAROLD
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-23S1
|
$75,930
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-23S2
|
$172,091
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-23S3
|
$175,726
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
UNMC Eppley Cancer Center Support Grant
|
5P30CA036727-23
|
$1,493,701
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
University of Texas SPORE in Prostate Cancer
|
3P50CA090270-05S1
|
$350,000
|
LOGOTHETIS, CHRISTOPHER
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-03S1
|
$56,787
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO ALBUQUERQUE
|
|
University of New Mexico Cancer Center Support
|
5P30CA118100-03
|
$1,319,186
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO ALBUQUERQUE
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-20S2
|
$59,280
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-20S3
|
$114,000
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
5P30CA046592-20
|
$5,929,129
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Michigan Comprehensive Cancer Center CCOP*
|
3U10CA074648-06S1
|
$14,723
|
Brenner, Dean
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Univ.of Calif., Irvine Cancer Center Support Grant
|
3P30CA062203-13S1
|
$68,952
|
MEYSKENS, FRANK
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
Univ.of Calif., Irvine Cancer Center Support Grant
|
3P30CA062203-13S2
|
$2,553,879
|
MEYSKENS, FRANK
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
Univ.of Calif., Irvine Cancer Center Support Grant
|
3P30CA062203-13S3
|
$59,791
|
MEYSKENS, FRANK
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
Unexpected Roles for the alpha2beta1 Integrin
|
5R01CA115984-03
|
$287,376
|
ZUTTER, MARY
|
VANDERBILT UNIVERSITY
|
|
Ultrasensitive FACTTassays for serum biomarkers
|
1R21CA116103-01A2
|
$176,927
|
XU, XIAOWEI
|
UNIVERSITY OF PENNSYLVANIA
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|